Abstract
Renal coloboma syndrome (RCS) and dominant optic atrophy are mainly caused by heterozygous mutations in PAX2 and OPA1, respectively. We describe a patient with digenic mutations in PAX2 and OPA1. A female infant was born without perinatal abnormalities. Magnetic resonance imaging at 4 months of age showed bilateral microphthalmia and optic nerve hypoplasia. Appropriate body size was present at 2 years of age, and mental development was favorable. Color fundus photography revealed severe retinal atrophy in both eyes. Electroretinography showed slight responses in the right eye, but no responses in the left eye, suggesting a high risk of blindness. Urinalysis results were normal, creatinine-based estimated glomerular filtration rate was 63.5 mL/min/1.73 m2, and ultrasonography showed bilateral hypoplastic kidneys. Whole exome sequencing revealed de novo frameshift mutations in PAX2 and OPA1. Both variants were classified as pathogenic (PVS1, PS2, PM2) based on the guidelines from the American College of Medical Genetics and Genomics (ACMG). Genetic testing for ocular diseases should be considered for patients with suspected RCS and a high risk of total blindness.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Groot ALW, Lissenberg-Witte BI, van Rijn LJ, Hartong DT (2022) Author’s reply to: Comment on: “Meta-analysis of ocular axial length in newborns and infants until three years of age”. Surv Ophthalmol 67:633–635. https://doi.org/10.1016/j.survophthal.2021.11.011
Schimmenti LA (2011) Renal coloboma syndrome. Eur J Hum Genet 19:1207–1212. https://doi.org/10.1038/ejhg.2011.102
Bower MA, Schimmenti LA, Eccles MR (2018) PAX2-Related Disorder. In: Adam MP, Feldman J, Mirzaa GM et al (eds) GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1451/. Accessed 20 Feb 2024
Delettre-Cribaillet C, Hamel CP, Lenaers G (2015) Optic Atrophy Type 1. In: Adam MP, Feldman J, Mirzaa GM et al (eds) GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1248/. Accessed 20 Febr 2024
Acknowledgements
The authors thank Shogo Nakada, Noriko Nakayama, Sadao Nakamura, Kazuya Hamada, Takuya Kaneshi, and Noriko Kinjo for useful discussions. The authors also thank Ryan Chastain-Gross, PhD, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript. This work was supported by the Initiative on Rare and Undiagnosed Diseases (IRUD).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and accompanying images.
Conflicts of interest
All authors have declared no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shimabukuro, W., Chinen, Y., Imanaga, N. et al. Renal coloboma syndrome/dominant optic atrophy with severe retinal atrophy and de novo digenic mutations in PAX2 and OPA1. Pediatr Nephrol (2024). https://doi.org/10.1007/s00467-024-06347-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00467-024-06347-z